Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics
暂无分享,去创建一个
G. Dougan | J. Parkhill | S. Bentley | T. Lithgow | S. Harris | J. Lacey | M. Davies | S. Tong | J. Carapetis | J. Lees | A. Steer | A. Mutreja | M. Holden | B. Currie | S. Duchêne | R. S. L. A. Torres | P. Smeesters | J. Berkley | A. Saul | J. Fraser | R. Strugnell | P. Giffard | N. Moreland | D. Williamson | Tania Rivera-Hernández | M. Walker | S. David | Kate A Worthing | H. Frost | D. Price | A. J. Cork | A. Seale | R. Towers | René Bergmann | Liam McIntyre | S. Tong | O. Berking | P. Nitsche-Schmitz | G. S. Chhatwal | R. S. Torres
[1] V. Nizet,et al. An Experimental Group A Streptococcus Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model , 2019, mBio.
[2] Jukka Corander,et al. Fast and flexible bacterial genomic epidemiology with PopPUNK , 2018, bioRxiv.
[3] Alexandre Souvorov,et al. SKESA: strategic k-mer extension for scrupulous assemblies , 2018, Genome Biology.
[4] K. Holt,et al. Distinct evolutionary dynamics of horizontal gene transfer in drug resistant and virulent clones of Klebsiella pneumoniae , 2018, bioRxiv.
[5] J. Corander,et al. Signatures of negative frequency dependent selection in colonisation factors and the evolution of a multi-drug resistant lineage of Escherichia coli , 2018, bioRxiv.
[6] Jukka Corander,et al. pyseer: a comprehensive tool for microbial pangenome-wide association studies , 2018, bioRxiv.
[7] V. Nizet,et al. Virulence Role of the GlcNAc Side Chain of the Lancefield Cell Wall Carbohydrate Antigen in Non-M1-Serotype Group A Streptococcus , 2018, mBio.
[8] M. Davies,et al. Scarlet Fever Epidemic in China Caused by Streptococcus pyogenes Serotype M12: Epidemiologic and Molecular Analysis , 2018, EBioMedicine.
[9] M. Gutmann,et al. Frequency-dependent selection in vaccine-associated pneumococcal population dynamics , 2017, Nature Ecology & Evolution.
[10] R. Lynfield,et al. Population and Whole Genome Sequence Based Characterization of Invasive Group A Streptococci Recovered in the United States during 2015 , 2017, mBio.
[11] Andrea Beaton,et al. Global, Regional, and National Burden of Rheumatic Heart Disease, 1990–2015 , 2017, The New England journal of medicine.
[12] C. Buchrieser,et al. Dynamics and impact of homologous recombination on the evolution of Legionella pneumophila , 2017, PLoS genetics.
[13] J. Coelho,et al. Whole genome sequencing of group A Streptococcus: development and evaluation of an automated pipeline for emmgene typing , 2017, PeerJ.
[14] Daniel H. Huson,et al. Neanderthal behaviour, diet, and disease inferred from ancient DNA in dental calculus , 2017, Nature.
[15] S. Koren,et al. Canu: scalable and accurate long-read assembly via adaptive k-mer weighting and repeat separation , 2016, bioRxiv.
[16] R. Guy,et al. Genome analysis following a national increase in Scarlet Fever in England 2014 , 2017, BMC Genomics.
[17] Jukka Corander,et al. Efficient Inference of Recent and Ancestral Recombination within Bacterial Populations , 2016, bioRxiv.
[18] M. Venkataswamy,et al. Oral immunization of mice with recombinant rabies vaccine strain (ERAG3G) induces complete protection , 2015, Clinical and Experimental Vaccine Research.
[19] G. Khazen,et al. Genome Analysis of Streptococcus pyogenes Associated with Pharyngitis and Skin Infections , 2016, PloS one.
[20] B. Shapiro,et al. Phenotypic differentiation of Streptococcus pyogenes populations is induced by recombination-driven gene-specific sweeps , 2016, Scientific Reports.
[21] Khalil Abudahab,et al. Microreact: visualizing and sharing data for genomic epidemiology and phylogeography , 2016, Microbial genomics.
[22] Cheryl P. Andam,et al. Recombination in Streptococcus pneumoniae Lineages Increase with Carriage Duration and Size of the Polysaccharide Capsule , 2016, mBio.
[23] Julian Parkhill,et al. Robust high-throughput prokaryote de novo assembly and improvement pipeline for Illumina data , 2016, bioRxiv.
[24] David S. Wishart,et al. PHASTER: a better, faster version of the PHAST phage search tool , 2016, Nucleic Acids Res..
[25] Peer Bork,et al. Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees , 2016, Nucleic Acids Res..
[26] Manisha Pandey,et al. Combinatorial Synthetic Peptide Vaccine Strategy Protects against Hypervirulent CovR/S Mutant Streptococci , 2016, The Journal of Immunology.
[27] Jukka Corander,et al. Sequence element enrichment analysis to determine the genetic basis of bacterial phenotypes , 2016, Nature Communications.
[28] Mark R. Davies,et al. Invasive Group A Streptococcus Infection among Children, Rural Kenya , 2016, Emerging infectious diseases.
[29] Michael D. Jones,et al. Emergence of a New Highly Successful Acapsular Group A Streptococcus Clade of Genotype emm89 in the United Kingdom , 2015, mBio.
[30] P. Brzoska,et al. Using Whole Genome Analysis to Examine Recombination across Diverse Sequence Types of Staphylococcus aureus , 2015, PloS one.
[31] Michael J E Sternberg,et al. The Phyre2 web portal for protein modeling, prediction and analysis , 2015, Nature Protocols.
[32] Andrew J. Page,et al. Roary: rapid large-scale prokaryote pan genome analysis , 2015, bioRxiv.
[33] Jacqueline A. Keane,et al. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins , 2014, Nucleic acids research.
[34] A. von Haeseler,et al. IQ-TREE: A Fast and Effective Stochastic Algorithm for Estimating Maximum-Likelihood Phylogenies , 2014, Molecular biology and evolution.
[35] G. Dougan,et al. Emergence of scarlet fever Streptococcus pyogenes emm12 clones in Hong Kong is associated with toxin acquisition and multidrug resistance , 2014, Nature Genetics.
[36] Michael W Parker,et al. A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development. , 2014, The Journal of infectious diseases.
[37] M. Sternberg,et al. SuSPect: Enhanced Prediction of Single Amino Acid Variant (SAV) Phenotype Using Network Features , 2014, Journal of molecular biology.
[38] Torsten Seemann,et al. Prokka: rapid prokaryotic genome annotation , 2014, Bioinform..
[39] V. Nizet,et al. The classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine design. , 2014, Cell host & microbe.
[40] A. Nerlich,et al. Distribution of small native plasmids in Streptococcus pyogenes in India. , 2014, International journal of medical microbiology : IJMM.
[41] M. Quail,et al. Global Population Structure and Evolution of Bordetella pertussis and Their Relationship with Vaccination , 2014, mBio.
[42] S. W. Long,et al. Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences , 2014, Proceedings of the National Academy of Sciences.
[43] Timothy C. Barnett,et al. Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus , 2014, Clinical Microbiology Reviews.
[44] N. Fittipaldi,et al. Deriving Group A Streptococcus Typing Information from Short-Read Whole-Genome Sequencing Data , 2014, Journal of Clinical Microbiology.
[45] M. Parker,et al. Structural studies of Streptococcus pyogenes streptolysin O provide insights into the early steps of membrane penetration. , 2014, Journal of molecular biology.
[46] Jukka Corander,et al. Dense genomic sampling identifies highways of pneumococcal recombination , 2014, Nature Genetics.
[47] M. Lipsitch,et al. Population genomics of post-vaccine changes in pneumococcal epidemiology , 2013, Nature Genetics.
[48] M. Pirmohamed,et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile , 2012, Nature Genetics.
[49] C. Gillen,et al. Group a streptococcal vaccine candidates: potential for the development of a human vaccine. , 2013, Current topics in microbiology and immunology.
[50] V. Nizet,et al. Conserved anchorless surface proteins as group A streptococcal vaccine candidates , 2012, Journal of Molecular Medicine.
[51] J. Musser,et al. Multi High-Throughput Approach for Highly Selective Identification of Vaccine Candidates: the Group A Streptococcus Case , 2012, Molecular & Cellular Proteomics.
[52] J. Corander,et al. Detection of recombination events in bacterial genomes from large population samples , 2011, Nucleic acids research.
[53] T. Penfound,et al. New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci. , 2011, Vaccine.
[54] Ying Gao,et al. Bioinformatics Applications Note Sequence Analysis Cd-hit Suite: a Web Server for Clustering and Comparing Biological Sequences , 2022 .
[55] J. Carapetis,et al. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. , 2009, The Lancet. Infectious diseases.
[56] J. Tagg,et al. Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics. , 2009, Future microbiology.
[57] P. O’Toole,et al. Model for substrate interactions in C5a peptidase from Streptococcus pyogenes: A 1.9 A crystal structure of the active form of ScpA. , 2009, Journal of molecular biology.
[58] X. Didelot,et al. A comparison of homologous recombination rates in bacteria and archaea , 2009, The ISME Journal.
[59] R. Lynfield,et al. Plasmid-Borne erm(T) from Invasive, Macrolide-Resistant Streptococcus pyogenes Strains , 2008, Antimicrobial Agents and Chemotherapy.
[60] Ziheng Yang. PAML 4: phylogenetic analysis by maximum likelihood. , 2007, Molecular biology and evolution.
[61] F. González-Candelas,et al. Population structure and recombination in environmental isolates of Legionella pneumophila. , 2007, Environmental Microbiology.
[62] M. Juliano,et al. Towards a Vaccine Against Rheumatic Fever , 2006, Clinical & developmental immunology.
[63] J. Zabriskie,et al. Group A streptococcus (GAS) carbohydrate as an immunogen for protection against GAS infection. , 2006, The Journal of infectious diseases.
[64] J. Carapetis,et al. The global burden of group A streptococcal diseases. , 2005, The Lancet. Infectious diseases.
[65] J. Langley,et al. Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[66] J. Musser,et al. Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events. , 2005, The Journal of infectious diseases.
[67] W. Hanage,et al. Using Multilocus Sequence Data To Define the Pneumococcus , 2005, Journal of bacteriology.
[68] Sylvain Brisse,et al. Multilocus Sequence Typing of Klebsiella pneumoniae Nosocomial Isolates , 2005, Journal of Clinical Microbiology.
[69] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[70] James D. Campbell,et al. Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial. , 2004, JAMA.
[71] Adeline R. Whitney,et al. Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[72] M. Davies,et al. Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection. , 2003, The Journal of infectious diseases.
[73] Brian G. Spratt,et al. Multilocus Sequence Typing of Streptococcus pyogenes and the Relationships between emm Type and Clone , 2001, Infection and Immunity.
[74] D. Jackson,et al. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population , 2000, Nature Medicine.
[75] Nicholas P. J. Day,et al. Multilocus Sequence Typing for Characterization of Methicillin-Resistant and Methicillin-Susceptible Clones ofStaphylococcus aureus , 2000, Journal of Clinical Microbiology.
[76] P. Cleary,et al. Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A Streptococcus , 1997, Infection and immunity.
[77] S. Subbarao,et al. Identification of isp, a locus encoding an immunogenic secreted protein conserved among group A streptococci , 1996, Infection and immunity.
[78] R. Facklam,et al. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci , 1996, Journal of clinical microbiology.
[79] K. Timmis,et al. The fibronectin binding domain of the Sfb protein adhesin of Streptococcus pyogenes occurs in many group A streptococci and does not cross-react with heart myosin. , 1994, Microbial pathogenesis.